eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 69
Original paper

Assessment of diagnostic value of cytological examination in lung carcinoma in own material obtained by EBUS and EUS methods

Piotr Wiśniewski, Maciej Głogowski, Włodzimierz Olszewski

Pol J Pathol 2018; 69 (3): 278-284
Online publish date: 2018/11/20
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
The aim of the study was the evaluation of the efficiency of cytological examination of the material obtained by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and endoscopic ultrasound bronchoscope-guided fine needle aspiration (EUSB-FNA) methods in the diagnosis of lung carcinoma. The usefulness was also assessed of the material obtained in that way for immunocytochemical and molecular tests in the diagnosis of non-small cell lung carcinoma. The material included cytological preparations obtained by EBUS and EUS methods. It was demonstrated that the technique made it possible to obtain diagnostic material from 94% of patients. A retrospective thorough analysis of those cases was the basis for the discussion of diagnostic difficulties.

lung carcinoma, EBUS-TBNA, EUSB-FNA, cytopathology

Krajowy Rejestr Nowotworów: http: //epid.coi.waw.pl/krn/.
Koss LG, Woyke S, Olszewski W. Aspiration biopsy. Cytologic interpretation and histologic bases. Igaku-Shoin. Second edition 1992; 288-321.
da Cunha Santos G, Saieg MA, et al. EGFR gene status in cytological samples of non small cell lung carcinoma: Controversies and opportunities. Cancer Cytopathol 2011; 119: 80-91.
Boldrini L, Gisfredi S, Ursino S, et al. Mutational analysis in cytological specimens of advanced lung adenocarcinoma: A sensitive method for molecular diagnosis. J Thorac Oncol 2007; 2: 1086-1090.
Cai G, Wong R, Chhieng D, et al. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma. Cancer Cytopathol 2013; 121: 500-507.
Li AR, Chitale D, Riely GJ, et al. EGFR Mutations in Lung Adenocarcinomas. Journal of Molecular Diagnostics 2008; 10, 3: 242-248.
Izumo T, Matsumoto Y, Chavez C, et al. Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small lung cancer after EGFR thyrosine kinase inhibitor treatment. Pulm Med 2016; 16: 106.
Billah S, Stewart J, Staerkel G, et al. EGFR and KRAS mutations in lung carcinoma: Molecular testing by using cytology specimens. Cancer Cytopathol 2011; 119: 111-117.
Khode R, Larsen DA, Culbreath BC, et al. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas. CancerCytopathol 2013; 121: 361-369.
Li AR, Chitale D, Riely GJ, et al. EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFRgene copy number and immunohistochemical expression. J Mol Diagn 2008; 10: 242-248.
Travis WD, Brambilla E, Burke AP, et al. Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol 2015; 10: 1240-1242.
Langfort R. Klasyfikacja pTNM raka p³uca. Pol J Pathol 2010; 61 (suppl 1).
Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011; 6: 244-285.
Langfort R, Szo³kowska M, Szczepulska-Wójcik E, et al. Zalecenia dotycz¹ce oceny mikroskopowej ma³ych wycinków i roz-
mazów cytologicznych w diagnostyce raka niedrobnokomórkowego p³uca na podstawie rekomendacji przedstawionych przez IASLC/ATS/ERS. Pneumonol Alergol Pol 2011; 80: 172-177.
van Boerdonk RA, Daniels JM, Bloemena E, et al, High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasis. J Thorac Oncol 2013; 8: 711-718.
Dabbs D. Diagnostic immunohistochemistry. 2nd edition. Churchill Livingstone Elsevier, Philadelphia 2006.
Junhong Jiang, Browning R, Lechtzin N, et al. TBNA with and without EBUS: a comparative efficacy study for the diagnosis and staging of lung cancer. J Thorac Dis 2014; 6: 416-420.
Patelli M, Lazzari A, Poletti V, et al. Role of fiberoscopic transbronchial needle aspiration in the staging of N2 disease due to non-small lung cancer. Ann Thorac Surg 2002; 73: 407-411.
Nayak A, Sugrue C, Koenig S, et al. Endobronchial ultrasound guided transbronchial needle aspirate (EBUS-TBNA): a proposal for on-site adequacy criteria. Diagn Cytopathol 2012; 40: 128-137.
Kramer H, Sanders J, Post WJ, et al. Analysis of cytological specimens from mediastinal lesions obtained by endoscopic ultrasound-guided fine-needle aspiration. Cancer 2006; 108: 206-211.
Alsharif M, Andrade RS, Groth SS, et al. Endobronchial ultrasound-guided transbronchial fine-needle aspiration: the University of Minnesota experience, with emphasis on usefulness, adequacy assessment, and diagnostic difficulties. Am J Clin Path 2008; 130: 434-443.
Young Rak Choi, Jin Young An, Mi Kyeong Kim, et al. The diagnostic efficacy and safety of endobronchial ultrasound-guided transbronchial needle aspiration as an initial diagnostic tool Korean J Intern Med 2013; 28: 660-667.
Herth FJF, Eberhardt R, Vilmann P, et al. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006; 61: 795-798.
Navani N, Brown JM, Nankivell M, et al. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer. Am J Respir Crit Care Med 2012; 185: 1316-1322.
Feller-Kopman D, Yung RC, Burroughs F, et al. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration: a retrospective study with histology correlation. Cancer Cytopathol 2009; 117: 482-490.
Langfort R. Rola badañ patomorfologicznych w wyborze metody leczenia raka p³uca. Onkologia po Dyplomie 2016; 2: 42-47.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe